Replies to post #174 on PROLOR Biotech, Inc. (PBTH)

[someconcerns]

If you see the acquisition of PBTH by OPK as synergystic and that OPK can better bring the PBTH products to market, you might take the share swap and stay for the ride. After all, it would not be a taxable event.

OTOH, if you feel PBTH is fully valued or that OPK can't add value, then sell. You both appear to have adopted that stance.

While it is possible that one of the ambulance-chasing lawyers can extract more value for PBTH shareholders, I think it may be more likely that other entities might try to make a higher offer and snatch PBTH away. Frost only has around a 20% interest in PBTH and may be compelled to recuse himself anyway.

As I have OPK shares as well and find the Prolor technology exciting, I may just stick around for a while.